Showing 1 - 9 results of 9 for search 'Hemming Johansson', query time: 0.03s Refine Results
  1. 1
    Patients' knowledge and perceived understanding – Associations with consenting to participate in cancer clinical trials

    Patients' knowledge and perceived understanding – Associations with consenting to participate in cancer clinical trials by Yvonne Brandberg, Hemming Johansson, Mia Bergenmar

    Published 2016-04-01
    Get full text
    Article
  2. 2
    Patient satisfaction after implementation of person-centred handover in oncological inpatient care - A cross-sectional study.

    Patient satisfaction after implementation of person-centred handover in oncological inpatient care - A cross-sectional study. by Anna Kullberg, Lena Sharp, Hemming Johansson, Yvonne Brandberg, Mia Bergenmar

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma

    Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma by Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell

    Published 2023-02-01
    Get full text
    Article
  4. 4
    PB1924: INCIDENCE OF CARDIOVASCULAR AND BLEEDING EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL) TREATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS ON CONSECUTIVE PATIENTS FROM A WELL-DEFINED REGION.

    PB1924: INCIDENCE OF CARDIOVASCULAR AND BLEEDING EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL) TREATED WITH IBRUTINIB – A RETROSPECTIVE ANALYSIS ON CONSECUTIVE PATIENTS FRO... by Maria Andersson, Hemming Johansson, Anders Österborg, Agneta Månsson-Broberg, Lotta Hansson, Marzia Palma

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

    Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma by Johan Falkenius, Hemming Johansson, Rainer Tuominen, Marianne Frostvik Stolt, Johan Hansson, Suzanne Egyhazi Brage

    Published 2017-08-01
    Get full text
    Article
  6. 6
    Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer.

    Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. by Anders Näsman, Mircea Romanitan, Cecilia Nordfors, Nathalie Grün, Hemming Johansson, Lalle Hammarstedt, Linda Marklund, Eva Munck-Wikland, Tina Dalianis, Torbjörn Ramqvist

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

    Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial by Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt, on behalf of the SENOMAC Trialists’ Group

    Published 2017-05-01
    Get full text
    Article
  8. 8
    Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)

    Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM... by Ylva Naeser, Hildur Helgadottir, Johan Hansson, Christian Ingvar, Nils O. Elander, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Antonios Valachis, Dimitrios Papantoniou, Agneta Nordin Danfors, Hemming Johansson, Anders Sundin, Yvonne Brandberg, Gustav J. Ullenhag

    Published 2022-02-01
    Get full text
    Article
  9. 9
    Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial

    Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Rand... by Magnus Nilsson, Magnus Nilsson, Halla Olafsdottir, Halla Olafsdottir, Gabriella Alexandersson von Döbeln, Gabriella Alexandersson von Döbeln, Fernanda Villegas, Giovanna Gagliardi, Mats Hellström, Qiao-Li Wang, Hemming Johansson, Hemming Johansson, Val Gebski, Jakob Hedberg, Fredrik Klevebro, Fredrik Klevebro, Sheraz Markar, Sheraz Markar, Elizabeth Smyth, Pernilla Lagergren, Pernilla Lagergren, Ghazwan Al-Haidari, Lars Cato Rekstad, Eirik Kjus Aahlin, Bengt Wallner, David Edholm, Jan Johansson, Eva Szabo, John V. Reynolds, CS Pramesh, Naveen Mummudi, Amit Joshi, Lorenzo Ferri, Rebecca KS Wong, Rebecca KS Wong, Chris O’Callaghan, Jelena Lukovic, Jelena Lukovic, Kelvin KW Chan, Trevor Leong, Andrew Barbour, Mark Smithers, Yin Li, Xiaozheng Kang, Feng-Ming Kong, Yin-Kai Chao, Tom Crosby, Christiane Bruns, Hanneke van Laarhoven, Mark van Berge Henegouwen, Richard van Hillegersberg, Riccardo Rosati, Guillaume Piessen, Giovanni de Manzoni, Florian Lordick

    Published 2022-07-01
    Get full text
    Article

Search Tools: